TABLE 1.
Sample | Gag detection
|
Env detection
|
CD4 count | ||||
---|---|---|---|---|---|---|---|
Untreated (−RT) | DNasea
|
Untreated (−RT) | DNasea
|
||||
+RT | −RT | +RT | −RT | ||||
HIV-seropositive women | |||||||
YO117 | − | + | − | + | + | − | NT |
YO121 | − | + | − | − | − | − | 944 |
YO137 | − | + | − | + | + | − | 140 |
YO174 | − | + | − | + | + | − | 168 |
YO175 | − | + | − | − | + | − | NT |
YO182 | − | + | − | − | + | − | NT |
YO183 | − | − | − | − | − | − | NT |
YO184 | + | + | − | − | + | − | 109 |
YO189 | + | + | − | + | + | − | 155 |
YO215 | + | + | − | − | NT | NT | 379 |
YO235 | + | − | − | + | NT | NT | NT |
YO236 | + | + | − | + | + | − | 49 |
YO240 | + | + | − | + | NT | NT | 262 |
YO247 | + | + | − | − | + | − | NT |
YO252 | + | + | − | + | + | − | 169 |
YO253 | + | + | − | − | NT | NT | 104 |
YO264 | + | + | − | + | NT | NT | 348 |
YO274 | + | + | − | NT | + | − | 482 |
YO275 | + | − | − | NT | − | − | 213 |
YO278 | + | + | + | NT | + | − | NT |
YO287 | + | + | − | + | + | + | NT |
YO291 | + | + | − | + | + | − | 294 |
YO298 | + | + | − | + | + | − | 462 |
YO299 | + | + | − | + | + | − | 266 |
YO317 | + | + | − | − | + | − | 692 |
YO321 | − | + | − | + | + | − | 495 |
Total(+)b | 18/26 | 23/26 | 1/26 | 14/23 | 18/21 | 1/21 | |
HIV-seronegative women | |||||||
YO161 | − | − | − | − | − | − | NT |
YO163 | − | − | − | − | − | − | NT |
YO164 | − | − | − | − | − | − | NT |
YO169 | − | − | − | − | − | − | NT |
YO171 | − | − | − | − | − | − | NT |
YO173 | − | − | − | − | − | − | NT |
YO178 | − | − | − | − | − | − | NT |
YO179 | − | − | − | − | − | − | NT |
Total(+)b | 0/8 | 0/8 | 0/8 | 0/8 | 0/8 | 0/8 |
DNase, DNaseI treatment of sample prior to reverse transcription; NT, not tested.
Total(+), number of positive samples/number of samples tested.